Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicine for treating prostatic hyperplasia, and its preparation method

A prostatic hyperplasia and drug technology, which is applied in the direction of drug combination, medical formula, medical preparations containing active ingredients, etc., can solve problems such as unexplained etiology, and achieve obvious curative effect and anti-prostatitis effect

Pending Publication Date: 2020-04-07
贵州泰尔医药研究所
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There are many studies on the pathogenesis of benign prostatic hyperplasia, but the etiology has not yet been elucidated.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating prostatic hyperplasia, and its preparation method
  • Medicine for treating prostatic hyperplasia, and its preparation method
  • Medicine for treating prostatic hyperplasia, and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0113] Embodiment 1. The pill for the treatment of benign prostatic hyperplasia and preparation method thereof

[0114] Recipe: 2100g Polygonum cephalosporin, 1400g Feilongzhangxue, 1400g white mustard seed.

[0115] Preparation method: Weigh the above-mentioned medicine in proportion, add 6 times the amount of 70% ethanol to reflux and extract twice, each time for 2 hours, filter, and recover the ethanol from the filtrate, and set aside; add 8 times the amount of water to the dregs, decoct twice, Once for 1 hour, filter, concentrate the filtrate to a relative density of 1.05 at 50°C, and set aside; combine the concentrated solution, vacuum-dry it at 0.04Mpa to form a dry extract, and grind it into a fine powder; add 10% edible vinegar and a regular amount of honey as a wetting agent , made into pills, and dried.

[0116] Usage and dosage: take orally, 3 times a day, 5g-10g each time.

Embodiment 2

[0117] Embodiment 2. Capsules for the treatment of benign prostatic hyperplasia and preparation method thereof

[0118] Recipe: 1000g Polygonum headflower, 500g Feilongzhang blood, 500g white mustard seed.

[0119] Preparation method: Weigh the above-mentioned medicine in proportion, add 6 times the amount of 70% ethanol to reflux and extract twice, each time for 2 hours, filter, and recover the ethanol from the filtrate, and set aside; add 8 times the amount of water to the dregs, decoct twice, Once for 1 hour, filter, and the filtrate was concentrated to a relative density of 1.05 at 50°C, and set aside. Combine the concentrates, vacuum-dry them at 0.05Mpa to form a dry extract, grind them into fine powder, and fill them into capsules.

[0120] Dosage: Take orally, 3 times a day, 2-6 capsules each time.

Embodiment 3

[0121] Embodiment 3. tablet for the treatment of benign prostatic hyperplasia and preparation method thereof

[0122] Recipe: 1500g Polygonum cephalosporin, 800g Feilongzhangxue, 800g white mustard seed.

[0123] Preparation method: Weigh the above-mentioned medicine in proportion, add 6 times the amount of 70% ethanol to reflux and extract twice, each time for 2 hours, filter, and recover the ethanol from the filtrate, and set aside; add 8 times the amount of water to the dregs, decoct twice, Once for 1 hour, filter, and the filtrate was concentrated to a relative density of 1.05 at 50°C, and set aside. Combine the concentrates, vacuum-dry them at 0.05Mpa to form a dry extract, grind them into fine powder, add an appropriate amount of binder, granulate, dry, and compress to form a tablet.

[0124] Dosage: Take orally, 3 times a day, 2-6 tablets each time.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating prostatic hyperplasia and a preparation method thereof. The medicine is prepared from polygonum capitatum, asiatic toddalia root and semen brassicae. The medicine of the invention has obvious anti-inflammatory, analgesic and anti-prostatitis effects, can effectively treat prostatic hyperplasia, and has an obvious curative effect.

Description

technical field [0001] The invention relates to a medicine for treating benign prostatic hyperplasia and a preparation method thereof, belonging to the field of pharmaceutical technology. Background technique [0002] Prostatic hyperplasia (BPH) is one of the common diseases of middle-aged and elderly men, and its incidence is increasing with the aging of the global population. The incidence of benign prostatic hyperplasia increases with age, but there may not be clinical symptoms when there are hyperplasia lesions. The urban incidence rate is higher than that in the rural areas, and racial differences also affect the degree of proliferation. [0003] There are many studies on the pathogenesis of benign prostatic hyperplasia, but the etiology has not yet been elucidated. Possibly due to the disrupted balance of epithelial and stromal cell proliferation and apoptosis, other related factors: androgens and their interaction with estrogens, prostatic stromal-glandular epitheli...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/75A61P13/08
CPCA61K36/704A61K36/75A61K36/31A61P13/08A61K2236/333A61K2236/39A61K2236/331A61K2300/00
Inventor 张永萍刘明徐剑刘耀
Owner 贵州泰尔医药研究所